Kailayangiri et al. [131] found that inhibition of enhancer of zeste homolog 2 (EZH2) could induce the surface expression of GD2 in Ewing sarcoma cells, thereby enhancing the killing ability of anti-GD2 CAR-T cells against Ewing sarcoma cells. This evidence concerns the gene EZH2 and Ewing sarcoma.